版本:
中国

BRIEF-Obseva SA says it intends to advance OBE022 into Phase 2A proof-of-concept clinical trial in second half of 2017

May 18 Obseva SA

* Says intends to advance obe022 into a Phase 2A proof-of-concept clinical trial in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐